Cite
HARVARD Citation
Arm, J. et al. (n.d.). Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects. Clinical & experimental allergy. 44 (11), pp. 1371-1385. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arm, J. et al. (n.d.). Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects. Clinical & experimental allergy. 44 (11), pp. 1371-1385. [Online].